Berlin, 27th February 2015 – The teams led by Marie-Laure Yaspo at the Max Planck Institute for Molecular Genetics and by Hans Lehrach at Alacris Theranostics GmbH in Berlin are partners in a European consortium that recently obtained funding from the European Commission under the Horizon 2020 program to participate in a clinical research project […]